These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8086331)

  • 1. Peripheral factors in the management of congestive heart failure.
    Demopoulos L; LeJemtel TH
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):75-82. PubMed ID: 8086331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure].
    Huonker M; Keul J
    Z Kardiol; 2001 Nov; 90(11):813-23. PubMed ID: 11771449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral vascular remodeling in chronic heart failure: clinical relevance and new conceptualization of its mechanisms.
    Nakamura M
    J Card Fail; 1999 Jun; 5(2):127-38. PubMed ID: 10404352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral adaptation in chronic heart failure: therapeutic implications].
    Drexler H
    Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral circulatory response in cardiac failure.
    Le Jemtel TH; Katz SD; Sonnenblick EH
    Hosp Pract (Off Ed); 1991 Sep; 26(9):75-82. PubMed ID: 1894718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
    Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
    Drexler H; Kurz S; Jeserich M; Münzel T; Hornig B
    Am J Cardiol; 1995 Nov; 76(15):13E-18E. PubMed ID: 7484881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study.
    Wisløff U; Støylen A; Loennechen JP; Bruvold M; Rognmo Ø; Haram PM; Tjønna AE; Helgerud J; Slørdahl SA; Lee SJ; Videm V; Bye A; Smith GL; Najjar SM; Ellingsen Ø; Skjaerpe T
    Circulation; 2007 Jun; 115(24):3086-94. PubMed ID: 17548726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition.
    Drexler H; Hiroi M; Riede U; Banhardt U; Meinertz T; Just H
    Am J Cardiol; 1988 Sep; 62(8):82E-85E. PubMed ID: 3046293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer concepts in the medical management of patients with congestive heart failure.
    Weintraub NL; Chaitman BR
    Clin Cardiol; 1993 May; 16(5):380-90. PubMed ID: 8504571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control of the circulation: implications for congestive heart failure.
    Delehanty JM; Liang CS
    Prog Cardiovasc Dis; 1995; 38(1):51-66. PubMed ID: 7631020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive changes in the periphery and their therapeutic consequences.
    Drexler H; Münzel T; Riede U; Just H
    Am J Cardiol; 1991 May; 67(12):29C-34C; discussion 34C-35C. PubMed ID: 2021116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the peripheral circulation in heart failure.
    Drexler H
    Curr Opin Cardiol; 1995 May; 10(3):268-73. PubMed ID: 7612976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in management for heart failure: diuretics].
    Aoyagi T; Hirata Y
    Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral abnormalities in chronic heart failure.
    Adamopoulos S; Coats AJ
    Postgrad Med J; 1991; 67 Suppl 1():S74-9; discussion S79-80. PubMed ID: 1924083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
    Münzel T; Kurz S; Drexler H
    Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.